全球抗體生產市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

全球抗體生產市場需求預計將從2023年的230.9億美元達到2032年近714.9億美元的市場規模，2024-2032年研究期間複合年成長率為13.38%。

抗體生產是一種生物技術過程，其中產生用於診斷、治療或研究目的的特異性抗體。這涉及對動物進行免疫或使用細胞培養物來引發免疫反應，然後收穫免疫反應以獲得針對特定抗原的抗體。這些抗體也稱為免疫球蛋白，對於檢測疾病、進行研究和開發標靶治療至關重要。單株抗體技術等先進技術可以產生高度特異性的抗體，這對於推進醫學科學和個人化醫療至關重要。

市場動態

感染、病毒以及癌症、類風濕和慢性病等其他疾病的盛行率不斷上升是推動抗體生產市場成長的因素。醫學研究中心對研發項目和新產品的技術進步的投資不斷增加，預計將推動抗體生產的市場成長。許多藥品正在轉向生物製藥，這可能會推動抗體生產的市場成長。此外，預計標靶治療的日益使用將擴大抗體生產的整體市場成長。政府對抗體生產激勵措施的增加預計將推動市場成長。相反，抗體生產的總體成本以及嚴格的政府批准療法和藥物的政策可能會進一步阻礙抗體生產的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球抗體生產市場的每個細分市場進行了包容性評估。抗體生產產業的成長和趨勢為本研究提供了整體方法。

市場區隔

抗體生產市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

• 儀器（生物反應器（多用途生物反應器、一次性生物反應器）、層析系統、過濾系統）
• 消耗品（介質、緩衝液和試劑、色譜樹脂和色譜柱、過濾消耗品和配件、其他）
• 軟體

按流程

• 上游處理
• 下游加工

按類型

• 單株抗體
• 多株抗體抗體

按最終用途

• 製藥和生物技術公司
• 研究實驗室
• CRO 和 CDMO

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲抗體生產市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。抗體生產市場的主要參與者包括 Illumina Inc.、Thermo Fisher Scientific Inc.、Pacific Biosciences Of California Inc.、BGI、QIAGEN、Agilent Technologies、PerkinElmer Inc.、ProPhase Labs Inc.、Psomagen、Azenta US Inc.。競爭格局的整體看法，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：抗體生產 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按流程進行市場吸引力分析
  • 按類型分類的市場吸引力分析
  • 按最終用途分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球抗體生產市場分析：按產品

• 概述（按產品）
• 按產品分類的歷史和預測資料分析
• 儀器（生物反應器（多用途生物反應器、一次性生物反應器）、層析系統、過濾系統）
• 消耗品（介質、緩衝液和試劑、色譜樹脂和色譜柱、過濾消耗品和配件、其他）
• 軟體

第 6 章：全球抗體生產市場分析：依流程

• 按流程概述
• 按流程進行歷史和預測資料分析
• 上游處理
• 下游加工

第 7 章：全球抗體生產市場分析：按類型

• 按類型概述
• 按類型分析歷史和預測數據
• 單株抗體
• 多株抗體抗體

第 8 章：全球抗體生產市場分析：依最終用途分類

• 按最終用途分類的概述
• 按最終用途分類的歷史和預測資料分析
• 製藥和生物技術公司
• 研究實驗室
• CRO 和 CDMO

第 9 章：全球抗體生產市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 10 章：抗體生產公司的競爭格局

• 抗體生產市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 11 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Illumina Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Thermo Fisher Scientific Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Pacific Biosciences Of California Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• BGI
• 公司概況
• 公司收入
• 產品
• 最新動態
• QIAGEN
• 公司概況
• 公司收入
• 產品
• 最新動態
• Agilent Technologies
• 公司概況
• 公司收入
• 產品
• 最新動態
• PerkinElmer Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• ProPhase Labs Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Psomagen
• 公司概況
• 公司收入
• 產品
• 最新動態
• Azenta US Inc
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Antibody Production Market is presumed to reach the market size of nearly USD 71.49 Billion by 2032 from USD 23.09 Billion in 2023 with a CAGR of 13.38% under the study period 2024-2032.

Antibody production is a biotechnological process wherein specific antibodies are generated for diagnostic, therapeutic, or research purposes. This involves immunizing animals or using cell cultures to elicit an immune response, which is then harvested to obtain antibodies targeting particular antigens. These antibodies, also known as immunoglobulins, are pivotal in detecting diseases, conducting research, and developing targeted treatments. Advanced techniques such as monoclonal antibody technology allow for the creation of highly specific antibodies, which are critical in advancing medical science and personalized medicine.

MARKET DYNAMICS

The rising prevalence of infections, viruses, and other diseases like cancer, rheumatoid and chronic diseases are factors driving the market growth of antibody production. Growing investments by medical research centers for research and development projects and technological advancements for new launches are expected to propel the market growth of antibody production. Numerous pharmaceuticals are shifting towards biopharma which may drive the market growth of antibody production. Furthermore, the growing use of targeted therapies is anticipated to expand the overall market growth of antibody production. The rise in government incentives for antibody production is projected to drive market growth. On the contrary, the overall cost of antibody production and strict government policies for the approval of the therapies and drugs may further hamper the market growth of antibody production.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antibody Production. The growth and trends of Antibody Production industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antibody Production market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems)
• Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others)
• Software

By Process

• Upstream Processing
• Downstream Processing

By Type

• Monoclonal Antibody
• Polyclonal Antibody

By End-use

• Pharmaceutical and Biotechnology Companies
• Research Laboratories
• CROs and CDMOs

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antibody Production market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antibody Production market include Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences Of California Inc., BGI, QIAGEN, Agilent Technologies, PerkinElmer Inc., ProPhase Labs Inc., Psomagen, Azenta US Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ANTIBODY PRODUCTION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Process
  • 3.7.3 Market Attractiveness Analysis By Type
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Historic and Forecast Sales By Regions
• 5.4. Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Historic and Forecast Sales By Regions
• 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY PROCESS

• 6.1. Overview By Process
• 6.2. Historical and Forecast Data Analysis By Process
• 6.3. Upstream Processing Historic and Forecast Sales By Regions
• 6.4. Downstream Processing Historic and Forecast Sales By Regions

7. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY TYPE

• 7.1. Overview By Type
• 7.2. Historical and Forecast Data Analysis By Type
• 7.3. Monoclonal Antibody Historic and Forecast Sales By Regions
• 7.4. Polyclonal Antibody Historic and Forecast Sales By Regions

8. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-use
• 8.2. Historical and Forecast Data Analysis By End-use
• 8.3. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
• 8.4. Research Laboratories Historic and Forecast Sales By Regions
• 8.5. CROs and CDMOs Historic and Forecast Sales By Regions

9. GLOBAL ANTIBODY PRODUCTION MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTIBODY PRODUCTION COMPANIES

• 10.1. Antibody Production Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF ANTIBODY PRODUCTION INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Illumina Inc.
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Thermo Fisher Scientific Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Pacific Biosciences Of California Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. BGI
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. QIAGEN
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Agilent Technologies
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. PerkinElmer Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. ProPhase Labs Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Psomagen
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Azenta US Inc
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Market Sales By Geography (USD MN)
• Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Market Sales By Geography (USD MN)
• Software Market Sales By Geography (USD MN)
• Analysis By Process (USD MN)
• Upstream Processing Market Sales By Geography (USD MN)
• Downstream Processing Market Sales By Geography (USD MN)
• Analysis By Type (USD MN)
• Monoclonal Antibody Market Sales By Geography (USD MN)
• Polyclonal Antibody Market Sales By Geography (USD MN)
• Analysis By End-use (USD MN)
• Pharmaceutical and Biotechnology Companies Market Sales By Geography (USD MN)
• Research Laboratories Market Sales By Geography (USD MN)
• CROs and CDMOs Market Sales By Geography (USD MN)
• Global Antibody Production Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Antibody Production Report
• Market Research Process
• Market Research Methodology
• Global Antibody Production Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Process
• Market Attractiveness Analysis By Type
• Market Attractiveness Analysis By End-use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Instruments (Bioreactors (Multi-Use Bioreactors, Single-Use Bioreactors), Chromatography Systems, Filtration Systems) Market Sales By Geography (USD MN)
• Consumables (Media, Buffers and Reagents, Chromatography Resins and Columns, Filtration Consumables and Accessories, Others) Market Sales By Geography (USD MN)
• Software Market Sales By Geography (USD MN)
• Global Market Analysis By Process (USD MN)
• Upstream Processing Market Sales By Geography (USD MN)
• Downstream Processing Market Sales By Geography (USD MN)
• Global Market Analysis By Type (USD MN)
• Monoclonal Antibody Market Sales By Geography (USD MN)
• Polyclonal Antibody Market Sales By Geography (USD MN)
• Global Market Analysis By End-use (USD MN)
• Pharmaceutical and Biotechnology Companies Market Sales By Geography (USD MN)
• Research Laboratories Market Sales By Geography (USD MN)
• CROs and CDMOs Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.